210 related articles for article (PubMed ID: 22863800)
21. Influence of hydroxypropyl methylcellulose polymer on in vitro and in vivo performance of controlled release tablets containing alprazolam.
Mahaguna V; Talbert RL; Peters JI; Adams S; Reynolds TD; Lam FY; Williams RO
Eur J Pharm Biopharm; 2003 Nov; 56(3):461-8. PubMed ID: 14602191
[TBL] [Abstract][Full Text] [Related]
22. Optimization of tenofovir release from mucoadhesive vaginal tablets by polymer combination to prevent sexual transmission of HIV.
Notario-Pérez F; Cazorla-Luna R; Martín-Illana A; Ruiz-Caro R; Tamayo A; Rubio J; Veiga MD
Carbohydr Polym; 2018 Jan; 179():305-316. PubMed ID: 29111056
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
[TBL] [Abstract][Full Text] [Related]
24. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
Ravi PR; Ganga S; Saha RN
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
[TBL] [Abstract][Full Text] [Related]
25. Estimation of the percolation thresholds in acyclovir hydrophilic matrix tablets.
Fuertes I; Miranda A; Millán M; Caraballo I
Eur J Pharm Biopharm; 2006 Nov; 64(3):336-42. PubMed ID: 16876392
[TBL] [Abstract][Full Text] [Related]
26. Influence of sodium dodecyl sulfate on swelling, erosion and release behavior of HPMC matrix tablets containing a poorly water-soluble drug.
Zeng A; Yuan B; Fu Q; Wang C; Zhao G
Pharm Dev Technol; 2009; 14(5):499-505. PubMed ID: 19743948
[TBL] [Abstract][Full Text] [Related]
27. Optimization of piribedil mucoadhesive tablets for efficient therapy of Parkinson's disease: physical characterization and ex vivo drug permeation through buccal mucosa.
Çelik B; Özdemir S; Barla Demirkoz A; Üner M
Drug Dev Ind Pharm; 2017 Nov; 43(11):1836-1845. PubMed ID: 28665152
[TBL] [Abstract][Full Text] [Related]
28. Development of mucoadhesive microspheres of acyclovir with enhanced bioavailability.
Tao Y; Lu Y; Sun Y; Gu B; Lu W; Pan J
Int J Pharm; 2009 Aug; 378(1-2):30-6. PubMed ID: 19465102
[TBL] [Abstract][Full Text] [Related]
29. Controlled release polymeric ocular delivery of acyclovir.
Deshpande PB; Dandagi P; Udupa N; Gopal SV; Jain SS; Vasanth SG
Pharm Dev Technol; 2010; 15(4):369-78. PubMed ID: 19772377
[TBL] [Abstract][Full Text] [Related]
30. Application of design of experiments to optimizing novel gastroretentive drug delivery of simvastatin.
Jagdale S; Kurhe P; Kuchekar B; Chabukswar A
Curr Drug Deliv; 2013 Oct; 10(5):527-41. PubMed ID: 23607639
[TBL] [Abstract][Full Text] [Related]
31. Formulation development and human in vitro-in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin.
Turner S; Federici C; Hite M; Fassihi R
Drug Dev Ind Pharm; 2004 Sep; 30(8):797-807. PubMed ID: 15521326
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of sponge-like acyclovir ocular minitablets.
Refai H; Tag R
Drug Deliv; 2011 Jan; 18(1):38-45. PubMed ID: 20804440
[TBL] [Abstract][Full Text] [Related]
33. Preparation and evaluation of gastroretentive floating tablets of Silymarin.
Garg R; Gupta GD
Chem Pharm Bull (Tokyo); 2009 Jun; 57(6):545-9. PubMed ID: 19483331
[TBL] [Abstract][Full Text] [Related]
34. Dissolution of tablet-in-tablet formulations studied with ATR-FTIR spectroscopic imaging.
Wray PS; Clarke GS; Kazarian SG
Eur J Pharm Sci; 2013 Mar; 48(4-5):748-57. PubMed ID: 23291036
[TBL] [Abstract][Full Text] [Related]
35. Effect of Different Polymer Concentration on Drug Release Rate and Physicochemical Properties of Mucoadhesive Gastroretentive Tablets.
Agarwal S; Murthy RS
Indian J Pharm Sci; 2015; 77(6):705-14. PubMed ID: 26997698
[TBL] [Abstract][Full Text] [Related]
36. Statistical approach for assessing the influence of calcium silicate and HPMC on the formulation of novel alfuzosin hydrochloride mucoadhesive-floating beads as gastroretentive drug delivery systems.
Fahmy RH
AAPS PharmSciTech; 2012 Sep; 13(3):990-1004. PubMed ID: 22806818
[TBL] [Abstract][Full Text] [Related]
37. In vitro Evaluation of Acyclovir/Chitosan Floating Systems.
Ruiz-Caro R; Veiga MD
Materials (Basel); 2010 Dec; 3(12):5195-5211. PubMed ID: 28883376
[TBL] [Abstract][Full Text] [Related]
38. Chitosan-based mucoadhesive tablets for oral delivery of ibuprofen.
Sogias IA; Williams AC; Khutoryanskiy VV
Int J Pharm; 2012 Oct; 436(1-2):602-10. PubMed ID: 22842627
[TBL] [Abstract][Full Text] [Related]
39. Preparation and in vitro evaluation of sustained release tablet formulations of diclofenac sodium.
Savaşer A; Ozkan Y; Işimer A
Farmaco; 2005 Feb; 60(2):171-7. PubMed ID: 15752476
[TBL] [Abstract][Full Text] [Related]
40. Influence of Chitosan Swelling Behaviour on Controlled Release of Tenofovir from Mucoadhesive Vaginal Systems for Prevention of Sexual Transmission of HIV.
Notario-Pérez F; Martín-Illana A; Cazorla-Luna R; Ruiz-Caro R; Bedoya LM; Tamayo A; Rubio J; Veiga MD
Mar Drugs; 2017 Feb; 15(2):. PubMed ID: 28230790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
